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a  b  s  t  r  a  c  t
The  epidemiology  and  diagnosis  of  osteoarticular  infections  (OAI)  have  changed  considerably  in  recent
years,  partly  due  to  the development  of molecular  biology.  Kingella  kingae  is now recognized  as  the  most
frequent  pathogen  in children  under  4  years  of  age, while  methicillin-resistant  Staphylococcus  aureus
(SA)  has  been  increasingly  reported.  Although  the  clinical  course  of  OAI is mostly  benign,  with  shorter
antibiotic  regimens  and  simpliﬁed  treatments,  serious  functional  impairments  and  life-threatening  com-
plications  can  still  occur,  especially  in case  of delayed  diagnosis  or infection  caused  by  Panton-Valentine
leukocidin-producing  strains  of  SA. Newborns  and  patients  with  sickle  cell disease  have  greater  risk  of
orthopaedic  sequelae,  which  need to be detected  and  managed  early.  The  main  sequelae  of osteomyelitis
are  angular  limb  deformity,  due  to  partial  growth  arrest,  and  lower  limb  discrepancy.  Therapeutic  options
are guided  by  the  patient’s  age  and  predictions  at maturity.  The  main  complications  of  septic  arthritis
are  joint  stiffness  and  osteonecrosis.  The  procedures  to consider  are  arthrodesis,  joint reconstruction  in
immature  children,  and  arthroplasty  at the  end  of growth.
©  2014  Published  by Elsevier  Masson  SAS.. Introduction
Osteoarticular infections (OAI) are frequent in pediatrics, with
n annual incidence in developed countries between 10 and 25
er 100,000 children [1]. The physiopathology, clinical examina-
ion, and initial management have been thoroughly described in
hree previous teaching conferences [2–4], but the epidemiology
nd certain therapeutic protocols have evolved in recent times,
otably based on contributions from molecular biology. The objec-
ive of this study was therefore to relate the data recently reported
n the literature so as to optimize the initial treatment and thus
educe the risk of complications, and then to describe the situations
t risk of sequelae and detail the different treatment options.
. Epidemiology
Studies have found an increase in the incidence of OAI in the
ast 20 years, but this rise can be explained by the improvement of
iagnostic methods. Early MRI  investigations are now widespread,
nd the use of molecular biology techniques has considerably
educed (by more than 50%) the number of suspected cases of OAI
ithout the bacterium being identiﬁed [5]. Broad-spectrum PCR
6S as well as PCR speciﬁc to Kingella kingae (Kk) have become
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877-0568/© 2014 Published by Elsevier Masson SAS.highly useful tools and have demonstrated that this Gram-negative
bacillus, commensal of the upper airways, had become the most
frequent pathogen in children under 4 years of age (nearly 80%)
[5,6]. The clinical picture is often poor and progression benign, but
cases of intraosseous abscess have recently been reported [7].
The second important notion is the signiﬁcant world-
wide increase in the number of community-acquired infections
related to community-acquired methicillin-resistant Staphylococ-
cus aureus (CA-MRSA) already reported in 2008 by Ben Ghachem,
responsible for unusually severe clinical cases [8]. Depending on
the region in the United States, the percentage of CA-MRSA varies
between 9 and 76% (for the most part clone USA300), thus inﬂuenc-
ing the probabilistic antibiotic therapy protocols. In Europe, there
is great clonal diversity and the frequency in France is currently
evaluated at 5–10% [9].
3. Physiopathology
The physiopathology of OAI, resulting from the interaction
between the pathogen and the host’s immune reaction, has pre-
viously been described in detail [2]. However, certain aspects
should be reviewed to understand the genesis of the sequelae. In
osteomyelitis, the initial bacterial ﬁxation is metaphyseal, encour-
aged by the local vascular anatomy and the rarity of macrophages.
If it goes untreated, the infection will lead to the creation of a puru-
lent intraosseous collection that needs to be evacuated. Since the
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White blood cells >12,000/mL
Sedimentation rate >40 mm/h







































tCRP  >20 mg/L
echanical properties of the adjacent tissues vary with age, it can
e diffused along three trajectories:
toward the epiphysis in children under 18 months of age (risk of
osteoarthritis);
toward the periosteum (subperiosteal abscess, aggravating cor-
tical vascularization);
toward the diaphysis, especially in older children (pandiaphyseal
osteomyelitis).
The newborn presents particular features: greater permeability
f the growth plate and the existence of communication between
etaphyseal and epiphyseal vascularization (with no transphyseal
ommunication), making spread of infection toward the epiphysis
nd then toward the adjacent joint cavity easier [10]. Moreover, the
ortical bone of infants is thin and more permeable, thus favoring
he development of subperiosteal abscesses as well as the risk of
steoarthritis by diffusion within the joints whose metaphysis is
ntracapsular (hip, shoulder, elbow).
In cases of osteoarthritis, synovial involvement is the most often
ematogenic, and joint destruction is stimulated by the release of
roteolytic enzymes from both bacteria and the patient’s immune
eaction. There is joint effusion, a source of hyperpressure that is
armful to vascularization and that can result in cases of capsular
istension to subluxation and even to dislocation, notably in the
nfant’s hip.
. Risk factors for sequelae
.1. Diagnostic delay
Diagnostic and therapeutic delay is considered by the majority
f authors as the main risk factor for sequelae. Although a 4-day
elay has been suggested as acceptable in treatment of uncom-
licated osteomyelitis, septic arthritis of the hip is an extreme
mergency and should be treated within the ﬁrst 6–12 h of its
ourse [11]. When there is doubt between septic arthritis and tran-
itory acute synovitis of the hip, the Kocher criteria, secondarily
odiﬁed by Caird et al., can be used, with a positive predictive value
reater than 97.5% when all ﬁve parameters are present (Table 1)
12].
.2. Poorly adapted treatment
Treatment of uncomplicated osteomyelitis remains medical.
n osteoarthritis, the reference treatment is joint lavage through
rthrotomy, but the trend is turning toward minimally invasive
rthroscopic surgery, and some authors report one or several nee-
le puncture-lavage procedures with satisfactory results [13,14].
ntibiotic protocols remain variable, but it is recommended to
se high doses (called transosseous) and to respect regular 6-h
dministration intervals to guarantee good efﬁcacy. The duration of
reatment, traditionally from 4 to 6 weeks, can now be reduced tourgery & Research 101 (2015) S129–S137
2–4 days intravenously, followed by 20 days per os for osteomyeli-
tis and 10 days only for septic arthritis [15,16].
4.3. The newborn
The predisposing factors are prematurity, perinatal hypoxia,
and catheter placement (venous or umbilical). The speciﬁcities
of the newborn are the possibility of multifocal involvement and
the frequency of osteoarthritis because of the physiopathological
particularities described above. The severity also stems from the
frequent diagnostic delay given the difﬁculty of the exam and the
limited clinical expression. Indeed, fever and local signs are often
absent, the biological markers are initially only slightly disturbed,
and the diagnosis must be made based on irritability, refusal to feed,
a pseudoparalytic attitude, and any unexplained bacteremia. With
no clinically identiﬁable source, an ultrasound of the hip should
be taken given the high risk of necrosis or subluxation favored
by hyperpressure. The functional prognosis of these early OAIs
remains severe, with 47% painful hips at 40 years of follow-up after
septic arthritis occurring before the age of 3 months [17].
4.4. Sickle cell patients
Sickle cell patients are particularly at risk, especially if they are
homozygote SS. The risk of infection is related to a progressive
destruction of the spleen, an organ frequently involved in bacte-
rial destruction, and a decrease in serum complement, a substance
that normally activates phagocytosis of neutrophils. The existence
of bone infarct is also a favorable background. The most frequently
blamed pathogens are Salmonella species (60–80% of cases), whose
passage in the blood stream is facilitated by occlusion of the diges-
tive tract capillary vessels. The main difﬁculty is making an early
distinction between vaso-occlusive crisis (VOC) and OAI. The local
clinical signs are often similar, whereas biology and imaging tests
have low speciﬁcity. The prognosis is related to the rapidity of treat-
ment, and one must therefore multiply the exams to develop a
collection of diagnostic arguments and discuss each case in a mul-
tidisciplinary fashion [18]. It should be remembered, however, that
VOC is much more frequent than OIA and that the latter often occurs
on a poorly vascularized bone segment that has already undergone
several infections.
4.5. SA-secreting Panton-Valentine toxin
The past decade has experienced a worldwide emergence
of infections caused by Panton-Valentine leukocidin (PVL)-
producing strains, responsible for multiple and severe bone
pathology [9]. Diagnosis is based on identiﬁcation of the toxin
or demonstration of PVL-coding genes. More often produced by
MRSA (notably community-acquired) than methicillin-susceptible
S. aureus (MSSA), the toxin causes tissue necrosis and destruc-
tion of the neutrophils, thus facilitating extension of the infection
[19,20]. Treatment is urgent given the risk of toxic shock and the
life-threatening nature of the infection. If in doubt before the micro-
biological conﬁrmation, probabilistic antibiotic therapy must be
associated with an antitoxin such as clindamycin or rifampicin.
Bacteremia can persist for several days despite effective antibiotic
therapy, and the number of surgical interventions and the length
of the hospital stay are often increased. The risk of complications is
high, with, notably, subperiosteal abscesses, pyomyositis, necros-
ing fasciitis, as well as a high incidence of deep vein thrombosis
(Fig. 1). The rate of orthopaedic sequelae varies in the literature
from 33 to 85%.





















Fig. 3. Progressive coxa valga in a 15-year-old boy, following neonatal osteoarthritis
Fig. 1. Pyomyositis of glutei and iliopsoas during PVL-secreting SA OAI.
. Treatment of orthopaedic sequelae
.1. Osteomyelitis sequelae
.1.1. Lateral epiphysiodesis
Involvement of a part of the germinal cells can lead to
rreversible growth arrest (epiphysiodesis), manifesting as an axial
eviation of the limb. Desepiphysiodesis can be proposed in cases
ith less than 50% bone bridge of the tibial shaft surface (CT or MRI)
nd if there remains at least 2 years of residual growth. The bridge is
esected either through a metaphyseal tunnel (Langenskiöld tech-
ique) or after having performed a physeal progressive distraction
Bollini technique) [21,22]. The principle is based on interposition
f a natural or synthetic inert material after resection, which is even
ore effective if it is attached to the epiphysis [23]. The results
eported in the literature remain controversial, inﬂuenced by the
tiology of the bridge location. The peripheral forms seem more
ccessible, but failures are frequent in OAI recovery because the
artilage can be damaged beyond the bridge zone. MRI  can there-
ore have a prognostic value preoperatively to assess the thickness
f the tibial shaft and estimate its residual growth potential.
When the residual growth is less than 2 years (12 bone age years
or girls and 14 bone age years for boys), it is preferable to complete
he epiphysiodesis and associate corrective osteotomy (Fig. 2).
Fig. 2. Postinfectious medial epiphysiodesis of the distal tibia in a 10-year-old girof  the hip.
5.1.2. Limb length discrepancy
5.1.2.1. Lower limb length discrepancy. More extended damage to
the tibial shaft can result in lower limb length discrepancy (LLLD).
Use of low-dose EOS stereoradiography (EOS imaging, Paris, France)
is particularly advantageous here because it can quantify (in 3D)
the discrepancy, even in case of ﬁxed sagittal deformities [24]. The
younger the child is and the more the damaged tibial shaft partici-
pates in overall growth of the limb, the more progressive LLLD will
be. Treatment will therefore be guided by the child’s age, the prog-
nosis in terms of ﬁnal height, and the predicted discrepancy at the
end of growth. Treatment will generally be envisaged in cases in
which the LLLD is greater than 2 cm.
The ﬁrst option is extemporaneous shortening, a simple method
used at the end of growth and normally reserved for the femur. The
current choice method is progressive shortening using epiphys-
iodesis, when the residual growth of the shortest limb is at least
equal to the limb length discrepancy.
The key component of the treatment remains the planning stage,
which should be repeated and carried out rigorously. The proﬁle of
postinfectious epiphysiodesis is most often linear (Shapiro type I),
making the prediction of the ﬁnal discrepancy relatively reliable,
but types IV (linear, then a plateau, and then delayed progression)
can also be encountered, notably in the proximal femur (Fig. 3) [25].
The prediction methods, for the most part based on bone age and
l, treated with supramalleolar osteotomy and epiphysiodesis complement.































sFig. 4. Patient presenting a 5.5-cm LLLD prognosis, treated with epiph
he Green and Anderson tables, were thoroughly detailed by Karger
n the 1998 GEOP monograph and then by Bronfen in 2009 [26,27].
In cases of greater discrepancy or at the end of growth, progres-
ive lengthening of the limb can be proposed, possibly associated
ith epiphysiodesis of the opposite side. The principle is based on
engthening of the osseous callus (callotasis), at a speed of 1 mm
er day, while maintaining joint range of motion and monitoring
he adjacent joints. The reference technique is the external ﬁxator,
ircular or monoplanar, but the recent trend is the development
f intramedullary nails, better accepted by patients and limiting
isﬁgurement. Orthoﬁx intramedullary skeletal kinetic distractor
ISKD) nails have been used for more than 10 years and require
xternal maneuvers to obtain lengthening (Fig. 4). The clinical
esults are highly encouraging, but lengthening failures and most
articularly excessively rapid gains in length have been reported
28]. The current trend is the development of implants allowing
assive lengthening, with either motorized (Fitbone nail) or mag-
etic (Phenix and Precice nails) devices, but these fairly rare and
xpensive techniques are still in the evaluation phase [29,30]. In
he postinfectious context, a prior study of the medullary cavity
ill always be necessary, because modiﬁcations in its diameter can
ake nailing difﬁcult, as will an assessment of the risk of reac-
ivating infection, given the risk of pandiaphysitis with material
hat has an uncertain prognosis, and an evaluation of the mobility,
uality (chondrolysis?), and stability of the adjacent joints.
.1.2.2. Upper limb length discrepancy. Damage to the proximal
xtremity of the humerus in the young child can result in major
hortening (8–10 cm)  of the upper limb. Lengthening with an
xternal ﬁxator, either monoplanar or circular, can be proposed in
ases of discrepancy greater than 5 cm,  with a bone union speed
lower than what has been observed for the lower limbs. The mainsis of the left knee and intramedullary lengthening of the right femur.
complications reported are iterative fractures, elbow stiffness,
varus deviations, and paralysis of the radial nerve [31].
5.1.3. Pandiaphyseal osteomyelitis
Pandiaphyseal osteomyelitis is a complication of chronic
osteomyelitis manifesting as radiological signs covering more than
75% of the diaphysis or as involvement of the opposite meta-
physis. Its long and complex treatment often requires repeated
interventions to drain the abscess and excise any sequestra. The
main complications are chronic ﬁstulization, joint stiffness, and
pathological fractures, immobilized with a cast or external ﬁxa-
tion [32]. There is a risk of evolving toward septic pseudarthrosis:
the treatment principles are excision (which should not be overly
extensive), stabilization, and then reconstruction. Monoplanar ﬁx-
ation is the most widely used for osteosynthesis, with or without a
cement spacer (induced membranes according to the Masquelet
technique), and the reconstruction takes place after 4–8 weeks
using a cancellous bone graft, if possible applied on the ﬁbula in
cases of tibial damage. The alternative methods are the Papineau
technique, the Ilizarov bone transfer technique, and vascularized
bone grafting, without any of these methods having been demon-
strated as superior.
5.2. Sequelae of osteoarthritis
5.2.1. Septic dislocation of the hip
If treatment has been delayed, in infants the abundance of the
joint effusion can result in capsular distension responsible for sub-
luxation or even dislocation of the coxofemoral joint. Emergency
treatment is the same as for osteoarthritis, but instability must also
be treated with a hip spica cast more or less frequently relayed by
an abduction orthosis for at least 3 months.















tig. 5. Osteonecrosis of the left proximal femur following neonatal osteoarthritis.
.2.2. Joint stiffness
Joint stiffness can be secondary to infection or consecutive
o prolonged immobilization, notably in cases of pathological
racture. Conservative treatment is often long and disappointing,
nd arthrolysis can be implemented at least 1 year after clinical
nd biological eradication of the infection, with results, however,
ore unpredictable than in post-traumatic ankylosis. In certain
ases, a corrective metaphyseal osteotomy can also be envisaged
o modify the joint’s range of motion and make it more func-
ional (distal femur extension osteotomy for knee ﬂessum, for
xample).
.2.3. Osteonecrosis
In cases with joint cartilage destruction, the therapeutic options
re arthrodesis, reconstruction surgery in young patients, and
rthroplasty at the end of bone growth (Fig. 5). The following details
he case of the hip, the most frequent location.
Fig. 6. Hip arthrodesis in a 14-year-old burgery & Research 101 (2015) S129–S137 S133
5.2.3.1. Arthrodesis treatment. Arthrodesis was  long the reference
treatment, because of the insufﬁcient survival rate for prostheses
in young patients (Fig. 6). This procedure still deserves consider-
ation because the long-term results are relatively favorable. The
vital component to guarantee patient satisfaction is complete infor-
mation on the objective of the intervention and the postoperative
period. It is indispensable to prevent future LLLD and the per-
sistence of asymmetry, but also to explain that the joint will no
longer be painful if bone fusion is acquired. Although the bone
nonunion rates in the early descriptions sometimes reached 50%,
the improvements in osteosynthesis have made it possible to obtain
bone union in more than 80% of cases. Two  studies with more
than 35 years of follow-up, with nearly half of the cases involv-
ing postinfectious situations, reported excellent quality of life
and underscored the subjects’ satisfaction, the majority of whom
had resumed a professional activity. The main problems reported
were spinal column pain (45–60%), pain in the homolateral knee
(55–60%) or in the ipsilateral hip (15–30%), and an underlying
increased risk of femur fracture [33,34]. The technical consider-
ations to take into account are keeping the abductor muscles intact,
with a potential future conversion to arthroplasty in view, as well
as the optimal position of the ﬁxation (20–30◦ ﬂexion, 5◦ adduction,
and 5–10◦ lateral rotation), thus limiting adjacent pain [35].
5.2.3.2. Conservative reconstruction surgery. Severe proximal
femur damage can result in residual cervical and/or cephalic
deformities. The Choi classiﬁcation, based on the extension of the
initial damage as well as on the radiological aspect at maturity,
is currently the most widely used to analyze these sequelae [36]
(Fig. 7). It is also the basis of a treatment algorithm (Fig. 8). Types III
and IV are considered severe sequelae, warranting reconstruction
surgery in the immature child to improve the functional prognosis
and delay any deﬁnitive procedure to the end of growth. The
goal of these interventions is to reduce acetabular dysplasia and
length discrepancy as well as to improve mobility. The functional
objective set out by Hunka et al. is to obtain a hip that is stable,
mobile (range of motion >50◦ and <20◦ ﬂessum) and painless,
allowing the child to participate in daily activities with no major
limping [38].
The choice procedure in types III is a proximal corrective femoral
osteotomy, associating valgus osteotomy and ﬂexion or extension,
with satisfactory 10-year results in more than 70% of stage IIIA
oy following septic osteonecrosis.









the acetabulum, which has been cleaned, and then to reattach theFig. 7. Choi classiﬁcation for hip osteoarthritis sequelae [36].
ases. Preoperative arthrography is very useful because it tests the
osition of the femur with the best congruence, thus orienting
oward the best adapted osteotomy procedure. Acetabuloplasty
an also be associated in the same operative time or secondarily
n cases of insufﬁcient cotyloid coverage. The results of stages
IIB (pseudarthrosis of the femur neck) and IV (destruction of
he femoral head and neck) cases are more irregular, especially
ince the majority of the series report a short follow-up period
Fig. 8. Choi treatment algorithm for hurgery & Research 101 (2015) S129–S137
and few patients. In these cases, surgery should be systematically
compared to therapeutic abstention while waiting for a future
prosthesis.
In stage IVA cases, therapy should be guided by the child’s age
and preoperative MRI, which assesses the cartilage stock remaining
above the femoral neck residue. If this is sufﬁcient and if the child
is under 6 years of age, modiﬁed Albee arthroplasty or a modiﬁed
Harmon intervention can be proposed (Fig. 9) [37,39]. The latter
procedure consists in an incomplete osteotomy of the remainder
of the femur, adjoining the greater trochanter to obtain an open-
ing effect ﬁlled with iliac graft with varus derotation and neck
lengthening. Other interventions should generally be planned dur-
ing follow-up such as a distal transfer of the greater trochanter,
acetabuloplasty, or a procedure to treat length discrepancy. Cheng
et al. also described vascularized iliac graft reconstruction, but the
results remain unpredictable [40].
In stage IVB cases with totally destroyed joint cartilage, the
options are therapeutic abstention until the end of growth, par-
ticularly if the hip is mobile and without pain, or reconstruction
surgery, with more unpredictable results that may lead to painful
stiffness that is less well tolerated than the initial condition. Before
6 years of age, trochanterplasty can be proposed, with the essen-
tial goal of preventing progressive dislocation of the femur in the
buttocks. Without a femoral head and neck, pelvic weight bear-
ing is returned to the femur on its trochanteric extremity, using
its remodeling potential [41]. The child should ﬁrst be placed in
traction so as to lower the femur. The ﬁrst procedure consists in
releasing the muscle attachments of the proximal femur (the glutei,
lateral vastus, iliopsoas, and lateral abductors and rotators of the
hip) and in positioning the greater trochanter in the bottom ofmuscle insertions. After 5–6 weeks with a stabilization cast, a varus
derotational osteotomy combined with an acetabuloplasty is per-
formed. The results of the trochanteroplasty remain controversial
ip osteoarthritis sequelae [37].

























3Fig. 9. Modiﬁed Harmon in
n the literature, with the main problems being uncertain vasculari-
ation of the proximal femur, progressive return of femoral valgus,
bductor stiffness and weakness, as well as difﬁcult conversion to
 prosthesis.
For these different reasons, the rescue treatment if the above
rocedures fail or in ﬁrst-line treatment in children over 6 years of
ge is Ilizarov hip reconstruction, combining a proximal pelvic sup-
ort osteotomy and more a distal femoral osteotomy to lengthen
he limb and realign the knee [42]. Proximal osteotomy creates val-
us and corrects ﬂessum and makes it possible to obtain pelvic
eight bearing by interposition of soft tissues between the prox-
mal femur fragment and the ischiatic tuberosity (Fig. 10). The
reater trochanter is lateralized and lowered, tightening the glutei
nd thus increasing the lever arm of the abductors. The number
f cases reported in the literature currently remains very limited,
ut the results seem excellent according to the authors in terms of
imping and LLLD. However, a risk of varus remodeling of the prox-
mal femur exists during follow-up, and pelvic support osteotomy
s therefore reserved for adolescents and young adults.
.2.3.3. Arthroplasty. Arthroplasty in the young subject has long
uffered from a poor reputation, but this can be partially attributed
o the fact that the main indication was chronic juvenile arthritis.
he 2007 SOFCOT symposium series reported a 50% survival rate for
n overall total hip arthroplasty (THA) prosthesis, implanted before
0 years of age, at 15 years of follow-up and 40% at 20 years [43]. Ation for Choi IVA sequelae.
recent meta-analysis on 736 THAs also demonstrated that aseptic
arthritis complications accounted for only 2.2% of the indications in
young subjects, demonstrating the reluctance of surgeons to pro-
pose arthroplasty in a postinfectious context [44]. Recent progress
has moved toward the use of cementless implants and the choice
of highly reticulated or metal–polyethylene or ceramic–ceramic
friction bearing components (hard–hard bearing), which have con-
siderably reduced the number of cases of loosening, notably at
the femoral level (Fig. 11) [43,44]. The 10-year survival rate of
hard–hard bearing components is now greater than 85%, with sat-
isfactory functional results.
The problems speciﬁc to the postinfectious context, detailed in
the review of the 74 cases presented at the 2007 SOFCOT sympo-
sium, are limb length discrepancy, frequent preoperatively, with a
mean 3-cm shortening that increases the risk of neurological injury,
and resulting proximal femur and acetabulum deformity. The sur-
vival rate of prostheses in this indication does not differ from those
found in the overall series, but the risk of infection (8%) is multiplied
by 3, despite delaying the procedure more than 10 years after the
initial infectious episode. The therapeutic approach recommended
to limit this risk is therefore taking intraoperative microbiologi-
cal samples covered by a standard antibiotic therapy (when the
bacterium is not known) or targeted to the initial bacterium and
interrupting antibiotic therapy after 48 h when the samples are
negative or adapting it to the bacterium found when the samples
are positive.
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Fig. 10. Ilizarov hip reconstruction principle, with proximal osteotomy correcting adduction and ﬂessum, and secondary, more distal osteotomy to realign and lengthen the
limb  [42].
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. Conclusion
Early diagnosis and adapted treatment are therefore the essen-
ial prognostic components to prevent orthopaedic sequelae.
ntervention of infectious disease specialists and multidisciplinary
eetings is therefore strongly recommended to optimize the man-
gement of OAI patients. Recent progress in surgery tends to
ncreasingly abandon conservative, disappointing treatments for
arly arthroplasty at the end of adolescence, taking into account,
owever, the risk of reactivating infection.
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